论文部分内容阅读
目的观察头孢哌酮钠/舒巴坦钠在慢性心力衰竭(CHF)合并肺部感染患者治疗中的应用效果。方法随机将我院收治的84例CHF合并肺部感染患者分成甲乙两组各42例，分别给予其头孢曲松钠与头孢哌酮钠/舒巴坦钠，观察两组治疗效果。结果甲组治疗总有效率为76.19%，相较于乙组的95.24%，差异显著(<0.05)；且两组患者在不良反应发生率方面比较差异显著(<0.05)。结论给予CHF合并肺部感染患者应用头孢哌酮钠/舒巴坦钠，整体效果显著。“,”Objective Observation of Cefoperazone/sulbactam in chronic heart failure (CHF)application in the treatment of patients with pulmonary infection.Methods Randomly treated in our hospital from 84 cases of CHF patients with pulmonary infection divided into a and B group with 42 cases in each were given the ceftriaxone and Cefoperazone/sulbactam,to observe the therapeutic ef ect of the two groups.Results Division in the treatment of total ef iciency was 76.19%,compared to the B group was 95.24%,significant dif erence( <0.05);and two groups of patients in adverse reactions occur ed rate dif erence was significant( <0.05).Conclusion For patients with cefoperazone sodium/sulbactam sodium CHF combined with pulmonary infection,the overal ef ect is significant.